Other

Dataset Information

0

The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [LACE-seq]

ABSTRACT: To reveal the potential targets of IGF2BP3 in Adenocarcinoma of the esophagogastric junction, we performed linear amplification of complementary DNA ends and sequencing (LACE-seq) in OE-19 cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE261199 | GEO | 2024/10/09

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [RIP-seq]
2024-10-09 | GSE261200 | GEO
Transcriptomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [RNA-seq]
2024-10-09 | GSE261202 | GEO
Other The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [meRIP-seq]
2024-10-09 | GSE261201 | GEO
Genomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [LACE-seq]
| PRJNA1085737 | ENA
Genomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [RIP-seq]
| PRJNA1085744 | ENA
Genomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [RNA-seq]
| PRJNA1085747 | ENA
Genomics The molecular mechanism and clinical significance of IGF2BP3 in adenocarcinoma of the esophagogastric junction [meRIP-seq]
| PRJNA1085748 | ENA
Methylation profiling m6A full transcriptome map of human adenocarcinoma of esophagogastric junction
2022-02-18 | GSE189874 | GEO
Genomics m6A full transcriptome map of human adenocarcinoma of esophagogastric junction
| PRJNA784934 | ENA
Genomics Gastric and esophagogastric junction adenocarcinoma with infrequent hypermethylation show poor prognosis
| PRJNA857438 | ENA